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2ABSTRACT
In Thailand diabetes mellitus is the most significant risk factor for melioidosis, a severe 
disease caused by Burkholderia pseudomallei. In this study, neutrophils isolated from healthy 
or diabetic subjects were infected with B. thailandensis E555, a variant strain with a B. 
pseudomallei-like capsular polysaccharide used here as a surrogate micro-organism for B. 
pseudomallei. At two hours post-infection, neutrophil proteins were subjected to 4-plex 
iTRAQ-based comparative proteomic analysis. A total of 341 proteins were identified in two 
or more samples, of which several proteins involved in oxidative stress and inflammation were 
enriched in infected diabetic neutrophils. We validated this finding by demonstrating that 
infected diabetic neutrophils generated significantly elevated levels of pro-inflammatory 
cytokines TNF, IL-6, IL-1 and IL-17 compared to healthy neutrophils. Our data also 
revealed that infected neutrophils from healthy or diabetic individuals undergo apoptotic cell 
death at distinctly different rates, with infected diabetic neutrophils showing a diminished 
ability to delay apoptosis and an increased likelihood of undergoing a lytic form of cell death, 
compared to infected neutrophils from healthy individuals. Increased expression of 
inflammatory proteins by infected neutrophils could contribute to the increased susceptibility 
to infection and inflammation in diabetic patients in melioidosis-endemic areas.
KEYWORDS: iTRAQ; Neutrophil; Diabetes mellitus; Burkholderia thailandensis; BTCV; 
Melioidosis
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3INTRODUCTION
Burkholderia pseudomallei, a facultative intracellular Gram-negative bacterium, is the 
causative agent of melioidosis. The disease is endemic in Southeast Asia and northern 
Australia, where mortality can be as high as 70% of infected adults in north-eastern Thailand. 
This bacterium has a complex intracellular lifestyle regulated by many virulence factors and 
has the ability to invade and replicate within host epithelial cells and phagocytic cells. B. 
thailandensis is genetically and phenotypically similar to B. pseudomallei, but considered to 
be avirulent. Despite being present in the soil of endemic areas at very high density, it has 
rarely been associated with clinical symptoms in humans and never associated with mortality 
1-3. Recently B. thailandensis strain E555 was isolated and characterized as a novel B. 
thailandensis with a B. pseudomallei-like capsular polysaccharide cluster 4, an essential 
virulence factor in mammals. This strain, and others like it, are commonly referred to as B. 
thailandensis capsule variants (BTCVs). BTCV strains share several B. pseudomallei-like 
phenotypes, including colony wrinkling, resistance to complement binding and enhanced 
intracellular survival in macrophages when compared to non-variant B. thailandensis 4. 
Furthermore, B. thailandensis E555 generated a protective immune response in a murine model 
of melioidosis in a similar manner as B. pseudomallei, raising the possibility that this strain 
could be a potential vaccine for melioidosis 5. At present, little is known about the host immune 
response to this BTCV strain which we believe could be a very useful surrogate microbe to aid 
in the study of the host cell: pathogen interactions that contribute to melioidosis.
Neutrophils are an essential human innate immune cell type involved in host 
inflammatory processes and immune surveillance, and are often the first cells to be recruited 
to a site of infection. They ingest bacteria by phagocytosis and destroy pathogens by a 
combination of reactive oxygen species (ROS), cationic peptides and proteolytic enzymes 
before undergoing apoptosis and terminating the local inflammation process. Several studies 
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4have demonstrated that neutrophils play an important role in melioidosis 6-10, through 
production and secretion of a variety of pro-inflammatory cytokines, for example gamma 
interferon (IFN-γ), an important cytokine for B. pseudomallei clearance in mice 11-13. Tumour 
necrosis factor (TNF-α), interleukin (IL)-1β and IL-6 are also important for bacterial clearance 
in murine models of acute and chronic melioidosis 14. Furthermore, neutrophils from healthy 
volunteers have also been shown to destroy B. pseudomallei through a process of extrusion of 
cellular contents including DNA, proteases and antimicrobial proteins in structures known as 
Neutrophil Extracellular Traps (NETs) 15, and through macroautophagy 16.
Diabetes mellitus (DM) is the most significant comorbidity risk factor for patients with 
melioidosis in Thailand. Up to 60% of melioidosis patients have pre-existing type 2 DM with 
acute rather than chronic infection 17. Glucose and glutamine play key roles in neutrophil 
function 18 and the hyperglycaemia status of DM patients has been reported to significantly 
correlate with neutrophil dysfunction 19, 20. The neutrophils of diabetic melioidosis patients 
demonstrate significant defects in migration, phagocytosis, ability to delay apoptosis 21 and 
reduced NET formation upon B. pseudomallei infection 15, when compared with neutrophils 
isolated from healthy subjects. 
To better understand the role of neutrophils in melioidosis, we have studied the proteome 
of neutrophils isolated from healthy donors and diabetic patients in response to the B. 
pseudomallei-like BTCV strain E555 using iTRAQ quantitative proteomics. We identified 341 
proteins in two or more samples and were able to calculate ratios for these proteins and 
demonstrate significant differences in the protein profiles of neutrophils from healthy and 
diabetic subjects. 
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5EXPERIMENTAL SECTION
Human subjects and ethics statement
This study was reviewed and approved by the Siriraj Ethics Committee for Human 
Research Protection Unit and written informed consent was obtained from all volunteers. 
Diabetic volunteers (n=4) had pre-existing type 2 diabetes (T2DM) with random blood glucose 
levels ≥200 mg/dl, fasting blood glucose levels ≥126 mg/dl, oral glucose tolerance test ≥200 
mg/dl, glycosylated haemoglobin A1c (HbA1c) levels ≥6.5%. Healthy volunteers (n=4) had 
normal blood counts, normal fasting blood glucose levels and normal glycosylated 
haemoglobin levels. 
Blood sample collection and neutrophil isolation
Human whole venous blood was collected from 4 healthy or diabetes mellitus volunteers 
with preservative-free lithium heparin as an anticoagulant. In brief, 5 ml of human whole 
venous blood was carefully layered over 5 ml of Polymorphprep reagent (13.8% (w/v) sodium 
diatrizoate, 8.0% (w/v) polysaccharide, density: 1.113 g/ml). After centrifugation at 600x g for 
40 min at 20oC, the PMNs (Figure S1) were collected before washing with PBS. After 
centrifugation at 400x g for 5 min at 20oC, the supernatant was discarded and contaminating 
RBCs were lysed with RBC lysis buffer. After centrifugation, the cell pellet was collected and 
washed with PBS before centrifugation at 400x g for 5 min at 20oC. The pellet was collected 
and re-suspended in RPMI1640 media containing 10% FBS (Thermo Scientific, MA) to obtain 
neutrophils with a routine viability of >96% (determined by 0.4% Trypan blue exclusion) and 
purity of >97%, (determined by microscopy and flow cytometry).
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6Neutrophil infection 
Human healthy or diabetic neutrophils were seeded to obtain 5x105 cells in a 24-well 
plate before infecting with B. thailandensis capsule-variant strain E555 (at mid-logarithmic 
phase of growth in LB broth) at an MOI of 5, with uninfected cells as negative controls. After 
incubation at 37oC with 5% CO2 for 30 min (T0), infected cells were washed with PBS before 
adding RPMI1640 containing 10% FBS and 250 µg/mL kanamycin to kill the extracellular 
bacteria. After incubation at 37oC with 5% CO2 for the indicated time points, infected 
neutrophils were washed and centrifuged at 500x g for 2 min. Supernatants were collected for 
cytokine analysis and for plating on LB agar to confirm a lack of viable extracellular bacteria. 
The cell pellet was collected and lysed using 1% Triton X-100 in PBS to enumerate the number 
of intracellular bacteria, or to isolate the total protein fractions for iTRAQ labelling and MS 
analysis. 
Protein extraction, digestion, iTRAQ labelling and LC-MS
About 1x106 neutrophils were mixed with 250µl 20mM Tris-pH 7.5, 200mM NaCl, and 
1% (w/v) octylthioglucoside before incubation for 1 h at room temperature with gentle 
agitation. The samples were centrifuged at 16,000x g for 20 min at 4oC and the supernatant 
containing the extracted protein collected. Protein samples were acetone precipitated, 
suspended in 100mM triethylammonium bicarbonate (TEAB) buffer containing 0.1% SDS and 
protein concentration determined. Aliquots containing 10g of protein from each condition 
were reduced with 5mM tris (2-carboxyethyl) phosphine (TCEP) for 1 hour at 60oC and 
alkylated with 10mM methyl methanethiosulfonate (MMTS) for 30 min in the dark at room 
temperature. In-solution digestion was performed with sequencing-grade trypsin (Promega 
Corporation) in a 1:20 mass ratio at 37oC. The resulting tryptic peptides were labelled with 
iTRAQ reagents (4-Plex system) according to the manufacturer’s instructions (Sciex, 
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7Warrington, UK). The 114 and 115 iTRAQ tags were used for the samples from normal 
uninfected (NM-) and infected (NM+) samples and the 116 and 117 tags were used for diabetic 
uninfected (DM-) and infected (DM+) samples, respectively. Briefly, iTRAQ labelling regents 
were dissolved in 70µL of ethanol and the contents were transferred to vials containing 
respective tryptic peptides. After 2 hours of incubation at room temperature, the reaction was 
quenched by adding an equal volume of water. Differentially labelled peptides were mixed and 
dried under vacuum.
The pooled iTRAQ labelled peptides were fractionated by basic pH reversed-phase 
chromatography on an XBridge BEH C18 (1 x 50 mm) column using a Dionex Ultimate 3000 
UHPLC system (ThermoFisher Scientific, UK). Briefly, the solvent gradients of buffer A (95% 
H2O and 5% ACN, pH 10,) and buffer B (5% H2O and 95% ACN, pH 10) were as follows: 
3%–5% B, 5 min; 5%–32% B, 25 min; 32%–95% B, 5 min; 95% B, 5 min; and 95%–3% B, 2 
min. The LC flow rate was set at 0.2 mL/min and monitored at 280 nm. The eluent was 
collected every 1 min. Fractions were desalted on Stage-Tip columns according to Rappsilber 
et al. 22. 
Peptide fractions were loaded on to an Acclaim PepMap100, C18, 100 Å, 75μm (internal 
diameter) × 15cm column using a Dionex UltiMate RSLCnano System (ThermoFisher 
Scientific, UK). The peptides eluted by reversed-phase chromatography were analysed by a 
micrOTOF-Q II mass spectrometer (Bruker Daltonics, Bremen, Germany) which was operated 
in data-dependent mode, automatically switching between MS and MS/MS mode. The m/z 
values of tryptic peptides were measured using a MS scan (300-2000 m/z), followed by MS/MS 
scans of the six most intense peaks. Rolling collision energy for fragmentation was selected 
based on the precursor ion mass and a dynamic exclusion was applied for 60 seconds.
Raw spectral data were processed by DataAnalysis software (Bruker Daltonics, Bremen, 
Germany) and the resulting peaklists were searched using Mascot 2.4 server (Matrix Science, 
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8UK) against the Uniprot Human sequence database containing 89,796 entries. Mass tolerance 
on peptide precursor ions was fixed at 25ppm and on fragment ions at 0.06Da. The peptide 
charge states were set as 2+ and 3+. iTRAQ modified N-terminal residue, iTRAQ modified 
lysine and methylthio modified cysteine were set as fixed modifications, while oxidation of 
methionine and iTRAQ modified tyrosine were set as variable modifications. The peptides 
were filtered to a FDR of lower than 1%, estimated using the target-decoy search strategy. 
iTRAQ quantification was performed by using WARPLC plugin on ProteinScape 3.1 software 
(Bruker Daltonics, Bremen, Germany) to extract reporter ion intensities of every MS/MS 
spectra with a requirement of two or more peptides. Peptide ratios were normalized based on 
setting overall peptide median ratio at one, which corrects for unequal protein sampling, and a 
coefficient of variability of peptide ratios were also determined for each quantified proteins.
Arbitrary cut-off values of iTRAQ ratios of ≥1.2 and of ≤0.8 were applied to the data to 
establish lists of differentially expressed proteins. Molecular functions and biological processes 
were inferred using a variety of online tools including Reactome (reactome.org). 
SDS-PAGE and Western blot analysis
Approximately 50 µg denatured protein samples were separated by 10-12% SDS-PAGE 
before transfer to a nitrocellulose membrane. Membranes were blocked with 5% skimmed milk 
protein before washing with PBST (PBS with 0.5% Tween-20). The membranes were then 
probed with anti-myeloperoxidase [2C7] (#ab25989, Abcam, UK), anti-S100A9 [D5O6O] 
(#72590, Cell signalling technology, USA) or anti-β-actin [D6A8] (# 8457, Cell signalling 
technology, USA) primary antibodies at a dilution of 1:1,000 before detecting using the 
relevant species HRP-conjugated secondary antibodies at a dilution of 1: 10,000. Bands were 
detected using Novex ECL Chemiluminescent Substrate Reagent Kit (ThermoFisher 
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9Scientific, USA). Images were captured using GeneSnap software version 7.02 (SynGene, 
USA).
Confocal microscopy
Neutrophils were seeded into a 6-well plate containing glass cover slips before infecting 
with B. thailandensis E555 at an MOI of 5 for 2 h as described above. Uninfected or B. 
thailandensis E555-infected neutrophils were fixed with 4% paraformaldehyde and 
permeabilized using 0.2% Triton-X 100 in PBS. Cells were then blocked with 3% BSA before 
incubating with anti-myeloperoxidase [2C7] (1:200; #ab25989, Abcam, UK), or anti- B. 
thailandensis E555 (1:100; kindly provided by Dr. Ganjana Lertmemongkolchai, Khon Kaen 
University, Thailand). Cells were then incubated with goat anti-mouse568 (1:500; #A-11004, 
ThermoFisher Scientific, USA) and goat anti-rabbit488 (1:500; #A27034, ThermoFisher 
Scientific, USA) secondary antibodies and counter-stained with 4'-6-diamidino-2-phenylindole 
(DAPI; 1:500; Molecular probes, USA). After incubation, cover slips were mounted and 
analysed by laser scanning confocal microscopy (LSM800, Carl Zeiss, Switzerland). 
Cytokine measurement by ELISA
Supernatants from both uninfected and infected cells were collected and filtered through 
0.22µm filters to remove any cell debris or intact viable bacteria. The concentrations of human 
IL-1β, IL-6, IL-8, TNF-α, IL-10 and IL-17A were determined using commercially available 
ELISA kits, according to the manufacturer’s instructions. Samples from three independent 
experiments (n=3 biological repeats), each with three intra-experiment technical replicates 
were assayed.
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10
Neutrophil apoptosis and LDH release assays
Neutrophil apoptosis was determined by flow cytometry using annexin V488/Dead cell 
apoptosis kit (ThermoFisher Scientific, USA), according to the manufacturer’s instructions. 
About 5x105 neutrophils were collected after 2 and 24 h post-infection before re-suspending 
with annexin-binding buffer. Then, 5μL of annexin V488 and 1μl of 100 μg/ml propidium iodine 
(PI) were added to each tube. After 15 min incubation, 400μl of annexin-binding buffer was 
added and the stained cells analyzed by flow cytometry (FACSCalibur, BD Biosciences, USA). 
Extracellular lactate dehydrogenase (LDH) released from uninfected or infected neutrophils 
were quantitatively determined in supernatants using a commercial LDH cytotoxicity assay kit 
(ThermoFisher Scientific, USA), following the manufacturer’s instructions. Samples from 
three independent experiments (n=3 biological repeats), each with three intra-experiment 
technical replicates were assayed for each cytokine.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 software (GraphPad, CA, 
USA). The unpaired Students t-test was applied for comparing the means of two independent 
sample groups. P-values less than 0.05 were considered statistically significant (*p-value < 
0.05, ** p-value < 0.01, and *** p-value < 0.001, ns; not significant; p-value > 0.05). 
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RESULTS & DISCUSSION
Bactericidal activity of neutrophils isolated from healthy and diabetic subjects 
There are few reports directly comparing the bactericidal activity of neutrophils from 
healthy and diabetic donors challenged in vitro with Burkholderia pseudomallei, and none that 
compare the responses of such cells to B. thailandensis or B. thailandensis capsule-variant 
(BTCV) strains. In this study, BTCV strain E555 was used as a surrogate model organism for 
B. pseudomallei due to its enhanced survival inside macrophage-like phagocytic cells in a 
manner dependent on the capsular polysaccharide gene cluster when compared to non-variant 
B. thailandensis 4, and also because it can be handled at lower containment with lower health 
risk to laboratory workers. To compare the responses of neutrophils to infection, we carefully 
screened potential donors and selected diabetic subjects with relatively poor glycemic control 
who were not medicated with glibenclamide. We excluded glibenclamide-treated patients 
based on the fact that Kewcharoenwong et al. 23 had previously demonstrated that 
glibenclamide drug treatment in DM patients significantly affected several neutrophil functions 
in response to B. pseudomallei infection. Fresh human whole venous blood were collected from 
either 4 healthy or 4 DM subjects and pooled together to reduce the variability between 
individual subjects such as age, weight and drug treatment, before isolation of the neutrophils.
Neutrophils were isolated from the blood of donors as described in the experimental 
section. Routinely, cells of more than 95% viability and 97% purity (as assessed by microscopy 
and flow cytometry analysis) were obtained (Figure S1). The neutrophils were first infected 
with B. thailandensis capsule variant (BTCV) strain E555 and the number of viable 
intracellular bacteria recovered at several time points thereafter. The number of viable bacteria 
recovered at 30 minutes, 2, 4 and 6 hours post-infection were calculated as a percentage of the 
initial inoculum used to infect the cells, and the data plotted. At 30 minutes post-infection (T0), 
a significant difference in the number of viable bacteria recovered from cells from healthy 
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subjects compared to cells isolated from diabetic donors was detected (Figure 1). This indicated 
that the diabetic neutrophils displayed a lower level of phagocytosis, as has been previously 
described 21, 24. Despite a reduced level of initial bacterial uptake (T0), the neutrophils from 
diabetic volunteers displayed significantly higher levels of bactericidal activity when compared 
to neutrophils from healthy volunteers at both 2 and 4 hours post-infection (Figure 1). Although 
by 6 hours post-infection, no significant difference in bactericidal activity between neutrophils 
from healthy or diabetic donors could be observed (Figure 1). These results are in accordance 
with those described by Chanchamroen et al. who demonstrated that whilst neutrophils from 
diabetic patients are less phagocytic, they show increased rates of bactericidal activity against 
B. pseudomalei over time 21.
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Figure 1. Comparison of the bactericidal activity of neutrophils isolated from healthy 
(NM) and diabetic (DM) volunteers. Neutrophils were infected with B. thailandensis E555 
at an MOI of 5. Cells were lysed at 30 minutes (T0), 2 (T2), 4 (T4) and 6 (T6) hours post-
infection for enumeration of viable bacteria. The number of intracellular live bacteria was 
expressed as a percentage of the initial inoculum using the equation [(number of intracellular 
viable bacteria at a single time point / number of bacteria in the inoculum)*100]. Each bar 
indicates the mean ± SEM from data obtained from 3 independent experiments (n=3 three 
biological replicates). An unpaired Students t-test was used to compare the numbers of 
intracellular bacteria recovered from healthy neutrophils to those recovered from diabetic 
neutrophils at each time point, where * indicates p-value ≤0.05.
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Characterisation of the neutrophil proteomes from healthy and diabetic donors
Neutrophils obtained from both healthy and diabetic donors were next infected with B. 
thailandensis E555 at an MOI of 5 for a total of 2 hours, before lysis and extraction of protein 
as described in the experimental section. Uninfected neutrophils treated under the same 
experimental conditions were lysed as control samples. Total protein samples of uninfected 
healthy neutrophils (NM-), B. thailandensis E555-infected healthy neutrophils (NM+), 
uninfected diabetic neutrophils (DM-) and B. thailandensis E555-infected diabetic neutrophils 
(DM+) were then subjected to 4-plex iTRAQ comparative proteomics analysis as outlined in 
Figure S2 and described in detail in the experimental section. Following LC-MS/MS, the raw 
spectral data were processed and protein identifications assigned. A total of 341 proteins were 
identified in two or more samples, allowing relative abundance ratios (fold changes) to be 
calculated for these proteins. Arbitrary cut-off values of >1.2 and <0.8 were applied to identify 
candidate proteins exhibiting increased or decreased expression respectively (Supplemental 
Table S1).
Comparison of the levels of proteins expressed by uninfected neutrophils (DM-/NM-) 
identified 86 proteins with a significant increase in expression in resting neutrophils from 
healthy donors, compared with neutrophils from diabetic donors. Conversely, 94 different 
proteins demonstrated an increased expression in uninfected neutrophils from diabetics 
compared to healthy donors (Table S1). To our knowledge, this is the first description of the 
proteome of neutrophils from diabetic patients. Pathway analysis of the proteins with increased 
expression in normal or diabetic neutrophils using the online Reactome resource, highlighted 
a large number of conserved pathways between healthy and diabetic subjects, as well as a few 
distinct pathways. Amongst the conserved pathways were those involved in antigen processing 
and presentation, interferon and cytokine signalling, and neutrophil degranulation. Perhaps 
unsurprisingly, two pathways that were unique to the normal neutrophils were 
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‘gluconeogenesis’ and ‘glucose metabolism’. Of significance when analysing the proteins with 
increased expression in diabetic cells, were proteins mapping to the ‘antimicrobial peptides’ 
pathway. These proteins were Eosinophil cationic protein, Protein S100-A8, Protein S100-A9, 
Cathepsin G, Myeloblastin, Neutrophil defensin 1, Peptidoglycan recognition protein 1 and 
Lactotransferrin. 
Within the lists of proteins that are significantly increased in either the resting neutrophils 
from healthy or diabetic donors, we noted that cells from diabetic patients over-expressed 
calpain, a potent activator of apoptosis in neutrophils. Conversely, cells from healthy subjects 
overexpressed calpastatin, an inhibitor of apoptosis in neutrophils, suggesting that cells from 
diabetics may be primed to undergo cell death or less able to delay spontaneous apoptosis in 
response to pathogens 25. In addition, we also noted the overexpression of a number of proteins 
in diabetic neutrophils involved in NET formation, a neutrophil specific mechanism of trapping 
and killing extracellular pathogens involving extrusion of cellular contents such as DNA, 
proteases and antimicrobial proteins, many of which are potent inflammatory mediators. 
Comparison with previous proteomic studies on the composition of NETs indicated that 13 
NET-associated proteins were identified in our study as significantly overexpressed in diabetic 
resting neutrophils 26-28. Resistin, originally identified as an insulin resistance factor 29 and more 
recently shown to be a potent activator of NETs 30, was also significantly overexpressed in 
neutrophils from diabetic volunteers.
Comparison of the proteome of neutrophils isolated from healthy and diabetic volunteers 
infected in vitro with BTCV E555
We further analysed our dataset by comparing the relative abundance of proteins in 
infected diabetic and infected healthy neutrophils (DM+/NM+, Table S1). Of the 316 proteins 
detected in both samples, 69 proteins demonstrated a significant increase in expression in 
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infected healthy neutrophils and 116 unique proteins were overexpressed in infected 
neutrophils from diabetics (Figure 2). The 30 proteins displaying the most extensive fold 
change in response to infection with this intracellular bacterium are listed in Table 1. This is 
the first proteomic comparison of the response of neutrophils from healthy and diabetic 
individuals. Mapping of these proteins onto molecular pathways using Reactome, confirmed 
that both infected healthy and diabetic neutrophils responded by increasing expression of 
proteins associated with the ‘innate immune system’ and ‘neutrophil degranulation’, with 
significantly more proteins mapping to these pathways from the infected diabetic cells. An 
increased number of proteins associated with innate immunity and neutrophil degranulation in 
infected diabetic neutrophils is suggestive of an increased inflammatory response by these cells 
compared to infected healthy neutrophils. Excessive neutrophil degranulation is a common 
cause of many inflammatory diseases, such as severe asphyxic episodes of asthma, acute lung 
injury, rheumatoid arthritis, and septic shock 31. Further evidence for an increased 
inflammatory response of diabetic neutrophils upon infection, comes from the fact that a 
significant number of proteins from infected diabetic cells mapped to pathways involved in 
interferon and cytokine signalling, antigen presentation and antimicrobial peptides. 
Conversely, pathways mapping to the proteins increased in healthy infected cells were limited 
to those involved in ‘calcineurin activation of NFAT’, glycolysis and gluconeogenesis, ‘IL12 
and JAK-STAT signalling’. 
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Figure 2. Venn diagram illustrating the numbers of common and unique proteins with 
increased expression upon infection of neutrophils isolated from either healthy or 
diabetic volunteers.  
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Table 1: Top 30 proteins with highest fold change upon infection of neutrophils from healthy or diabetic volunteers. Proteins with increased 
abundance upon infection of neutrophils from healthy volunteers (NM) are shown on the left hand side of the table (Fold change DM+/NM+ = 
≤0.8). Proteins with increased abundance upon infection of neutrophils from diabetic volunteers (DM) are shown on the right hand side of the 
table (Fold change DM+/NM+ = ≥1.2).
Overexpressed in infected NM neutrophils Overexpressed in infected DM neutrophils
Accession 
no.
Protein description Fold change 
(DM+/NM+)
Accession no. Protein description Fold change 
(DM+/NM+)
P60896 26S proteasome complex subunit SEM1 0.21 P12724 Eosinophil cationic protein 14.33
D6RC06 Histidine triad nucleotide-binding protein 1 0.22 K7EMV3 Histone H3 11.1
I3NI09 C-type lectin domain family 10 member A 0.27 Q9Y2K7-3 Isoform 3 of Lysine-specific 
demethylase 2A
10.45
Q8NA57 Uncharacterized protein C12orf50 0.29 P05164-2 Isoform H14 of Myeloperoxidase 8.63
P04406 Glyceraldehyde-3-phosphate dehydrogenase 0.3 A0A087WUA0 Fibrinogen alpha chain 6.97
P00558 Phosphoglycerate kinase 1 0.37 P11678 Eosinophil peroxidase 6.71
Q05315 Galectin-10 0.38 Q04760-2 Isoform 2 of Lactoylglutathione lyase 5.17
R4GN98 Protein S100 0.39 P08311 Cathepsin G 5.1
E5RIW3 Tubulin-specific chaperone A 0.4 O60814 Histone H2B type 1-K 4.51
P0DP23 Calmodulin-1 0.45 Q10567-4 Isoform 4 of AP-1 complex subunit 
beta-1
4.3
E7EQR4 Ezrin 0.46 E7ESK7 14-3-3 protein zeta/delta 4.04
H7C3I1 Hsc70-interacting protein 0.46 E9PMD7 Serine/threonine-protein phosphatase 3.64
P62328 Thymosin beta-4 0.47 E7EU81 Golgin subfamily B member 1 3.59
P38646 Stress-70 protein, mitochondrial 0.48 H7C320 Aldose 1-epimerase 3.56
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P04083 Annexin A1 0.5 Q5W0S5 UV excision repair protein RAD23 
homolog B
3.55
P05204 Non-histone chromosomal protein HMG-17 0.51 P48637 Glutathione synthetase 3.43
Q01518 Adenylyl cyclase-associated protein 1 0.52 E7ER44 Lactotransferrin 3.14
P62942 Peptidyl-prolyl cis-trans isomerase FKBP1A 0.53 P62805 Histone H4 3.01
H3BPC4 SUMO-conjugating enzyme UBC9 0.53 P15289-2 Isoform 2 of Arylsulfatase A 2.92
P07737 Profilin-1 0.54 P20618 Proteasome subunit beta type-1 2.74
P69905 Hemoglobin subunit alpha 0.54 I6L8B7 Fatty acid-binding protein, epidermal 2.65
P23284 Peptidyl-prolyl cis-trans isomerase B 0.54 F5H1S8 Malectin 2.59
C9JMM0 Chromobox protein homolog 3 0.55 P61626 Lysozyme C 2.53
Q32MZ4-3 Isoform 3 of Leucine-rich repeat flightless-
interacting protein 1
0.55 K7ESA3 Synaptic vesicle membrane protein 
VAT-1 homolog
2.52
P14780 Matrix metalloproteinase-9 0.56 P80511 Protein S100-A12 2.49
B7ZBK6 Delta-aminolevulinic acid dehydratase 0.56 C9J1Z8 ADP-ribosylation factor 5 2.47
M0QYG6 Uncharacterized protein 0.56 H7BZJ3 Protein disulfide-isomerase A3 2.37
P68036-2 Isoform 2 of Ubiquitin-conjugating enzyme 
E2 L3 
0.58 P07384 Calpain-1 catalytic subunit 2.32
P52566 Rho GDP-dissociation inhibitor 2 0.59 A0A0C4DFS8 Nicotinamide phosphoribosyltransferase 2.27
Q92820 Gamma-glutamyl hydrolase 0.61 P05109 Protein S100-A8 2.26
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Several proteins involved in oxidative stress were overexpressed in infected diabetic 
cells including myeloperoxidase and eosinophil peroxidase, which displayed 8.6 and 6.7 fold 
more protein in infected diabetic cells compared to infected healthy cells respectively (Table 
1). Interestingly, myeloperoxidase was also expressed at higher levels in uninfected diabetic 
cells compared to uninfected healthy cells, with a relative abundance ratio of 1.7. Similarly, we 
noted that the proteins S100-A8 and S100-A9, which together form the pro-inflammatory and 
anti-microbial complex calprotectin, were significantly increased in infected diabetic cells 
compared to infected neutrophils from healthy volunteers, with a relative abundance ratio of 
2.3 and 1.7 respectively. We chose to validate these findings by western blotting independently 
prepared samples of uninfected neutrophils from healthy donors (NM-), infected healthy 
neutrophils (NM+), uninfected neutrophils from diabetic donors (DM-) and infected diabetic 
neutrophils (Figure 3). As indicated by the proteomic data, myeloperoxidase could be detected 
in all samples, with an increased level of expression in resting neutrophils from diabetic donors 
compared to resting neutrophils from healthy donors. Myeloperoxidase expression increased 
upon infection, with significantly higher levels in the infected diabetic cells (Figure 3). This 
data correlates with a previous study by Morris et al. 32, who showed that myeloperoxidase 
release is significantly higher in whole blood of Type 2 DM patients than healthy controls upon 
B. pseudomallei infection. Excessive release of myeloperoxidase has been associated with 
severe local tissue inflammation through the generation of reactive halogenated and nitrated 
compounds in vivo 33. Similarly, we confirmed that expression of the inflammation-associated 
S100-A9 protein was also increased upon infection, with highest expression levels in infected 
diabetic cells (Figure 3). Increased expression of myeloperoxidase was also demonstrated in 
cells in vitro by immunostaining and confocal microscopy of uninfected and infected 
neutrophils (Figure 4). These findings support our hypothesis that diabetic neutrophils 
abundantly express inflammatory and oxidative stress mediators upon infection.
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Figure 3. Western blot analysis of Myeloperoxidase and S100-A9 in uninfected and B. 
thailandensis E555-infected healthy and diabetic neutrophils. Cells were incubated with 
media (uninfected) or with B. thailandensis E555 at an MOI of 5 for 2 hours. After lysis, 
separation by SDS-PAGE and transfer to nitrocellulose, the neutrophil proteins were detected 
with antibodies specific to myeloperoxidase (MPO) (upper panel), S100A9 (middle panel) or 
β-actin blotting (lower panel), which was used as a loading control. 
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Figure 4. Cellular localisation of Myeloperoxidase in uninfected and B. thailandensis 
E555-infected healthy or diabetic neutrophils. Neutrophils were incubated in media or with 
B. thailandensis E555 at an MOI of 5 for 2 hours. Cells were fixed and permeabilized before 
immunostaining with mouse anti-MPO and rabbit anti-LPS primary antibodies. Cells were then 
probed with goat-anti mouse568 and goat anti-rabbit488 to illustrate Myeloperoxidase 
localisation in red and bacteria in green. Host cell DNA was counter-stained with DAPI (blue). 
Each panel represents a composite image generated from several serial optical sections, using 
data captured with identical laser settings. Scale bar = 10m.
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Myeloperoxidase and calprotectin are also molecules extruded by neutrophils in NETs 
upon infection. We detected 18 NET-associated proteins 26-28 that were overexpressed in 
diabetic neutrophils compared to healthy neutrophils in response to infection (Table 2), 
although we did not investigate NET formation in this study. Whilst our data conflicts with a 
previous report that suggested that neutrophils from diabetic patients were less able to produce 
NETs in response to infection with B. pseudomallei 15, it is in agreement with a second study 
illustrating that NET markers are significantly elevated in the plasma of DM patients compared 
to healthy controls, and that these markers are further increased in DM patients with 
melioidosis 34. However, an alternative hypothesis could be that the biological difference in 
neutrophil responses lies in the ability of the cells to undergo degranulation, since many of the 
proteins in Table 2 and within the overall list of 116 proteins overexpressed by infected 
neutrophils from diabetic donors are associated with neutrophil degranulation and are potent 
inflammatory mediators. 
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Table 2. NET-associated proteins with increased expression in neutrophils from diabetic 
subjects following infection. Fold change refers to the abundance ratio in comparison with 
neutrophils isolated from healthy volunteers upon infection with B. thailandensis E555.
Accession no. NET-associated protein Fold change
P12724 Eosinophil cationic protein 14.3
K7EMV3 Histone H3 11.1
P05164-2 Isoform H14 of Myeloperoxidase 8.6
P08311 Cathepsin G 5.1
O60814 Histone H2B type 1-K 4.5
E7ER44 Lactotransferrin 3.1
P62805 Histone H4 3.0
P61626 Lysozyme C 2.5
P80511 Protein S100-A12 2.5
P05109 Protein S100-A8 2.3
C9JVG0 Serotransferrin 2.1
Q9HD89 Resistin 1.8
P06702 Protein S100-A9 1.7
P35579 Myosin-9 1.4
P12814 Alpha-actinin-1 1.3
P59665 Neutrophil defensin 1 1.3
U3KPS2 Myeloblastin 1.3
P25774 Cathepsin S 1.3
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Comparison of neutrophil cytokine production following infection 
The data presented in this study, particularly the increased levels of proinflammatory 
mediators in DM neutrophils both before and after infection, were suggestive of an increased 
inflammatory response in neutrophils from diabetic subjects when challenged in vitro with 
BTCV E555. Indeed others have demonstrated that B. pseudomallei can induce elevated levels 
of the pro-inflammatory cytokines TNF, IL-6, IL-8 and IL-12p70 in whole blood of diabetic 
subjects compared to healthy subjects 32. We assessed the levels of TNF, IL-6, IL-1 and IL-
10 in supernatants of neutrophils treated with media or infected with BTCV E555 for 2 and 24 
hours by ELISA (Figure 5). At 2 hours post-infection, TNF, IL-6 and IL-1 were elevated in 
the supernatants of both diabetic and healthy infected neutrophils (Figure 5A). Furthermore, 
TNF, IL-6 and IL-1 levels were significantly higher in infected diabetic neutrophils 
compared to infected healthy neutrophils, indicating that these cells were mounting a greater 
pro-inflammatory response. By 24 hours post-infection, only IL-1 remained significantly 
higher in the infected diabetic cells compared to the infected healthy cells (Figure 5B). 
IL-10 levels remained largely unchanged over time in control uninfected neutrophils, but 
did increase upon infection (Figure 5). As a key anti-inflammatory cytokine involved in 
dampening down inflammatory responses following successful control of pathogens, IL-10 
levels would be expected to increase at later time points of infection. Indeed, this was the case 
when comparing the IL-10 secretion at 2 hours post-infection of healthy neutrophils compared 
to 24 hours post-infection. IL-10 secretion was 7-fold higher in infected NM neutrophils at 2 
hours post-infection and 12-fold higher at 24 hours post-infection. However, infection of 
diabetic neutrophils resulted in lower levels of IL-10 at both 2 and 24 hours post-infection 
compared to infection of NM cells. Upon infection of DM neutrophils, a 4-fold and 5-fold 
increase in IL-10 was detected at 2 and 24 hours post-infection respectively, implying that these 
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cells lack the ability to regulate and dampen down the pro-inflammatory cytokine response 
following infection.
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Figure 5. Cytokine secretion by uninfected and E555-infected neutrophils from healthy 
and diabetic subjects. Neutrophils from healthy (NM) or diabetic (DM) volunteers were 
incubated with media or infected with B. thailandensis E555 at an MOI of 5 for 2 hours (T2) 
(A) and 24 hours (T24) (B). Secretion of IL-10, TNF, IL-6 and IL-1 in cell supernatants 
were detected by ELISA. An unpaired Students t-test was used to compare the means of two 
independent sample groups. Each bar indicates the mean ± SEM for data obtained from three 
independent experiments (n=3 biological replicates), where * = p-value ≤0.05, ** = p-value 
≤0.01 and *** = p-value ≤0.001.
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Neutrophils are a significant source of the pro-inflammatory cytokine IL-17, a cytokine 
with autocrine function which increases expression of other pro-inflammatory cytokines, 
proteases and reactive oxygen species, upon LPS stimulation 35. IL-17 has been linked to 
effective anti-fungal responses but also to chronic inflammatory conditions such as rheumatoid 
arthritis and psoriasis, and has been shown to be elevated in the circulation of Type 2 diabetes 
patients 36. Here we studied the secretion of IL-17A in neutrophils from healthy and diabetic 
subjects treated with media or BTCV E555 for 2 and 24 hours. Cells from healthy volunteers 
failed to stimulate an appreciable level of secreted IL-17, regardless of infection status (Figure 
6). Conversely, uninfected neutrophils from diabetic volunteers secreted readily detectable 
levels of IL-17 in the absence of infection (between 50-60pg/ml at both 2 and 24 hours) (Figure 
6). Significantly, levels of secreted IL-17 increased further upon infection of the diabetic 
neutrophils, and over time. 
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Figure 6. Secretion of IL-17 by uninfected and E555-infected neutrophils from healthy 
and diabetic subjects. Neutrophils from healthy (NM) or diabetic (DM) volunteers were 
incubated with media or infected with B. thailandensis E555 at an MOI of 5 for 2 hours (T2) 
(A) and 24 hours (T24) (B). Secretion of IL-17 in cell supernatants was detected by ELISA. 
Each bar indicates the mean ± SEM for data obtained from three independent experiments (n=3 
biological replicates). An unpaired Students t-test was used to compare the means of two 
independent sample groups, where ** indicates p-value ≤0.01.
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Comparison of rates of apoptosis in resting and infected neutrophils from healthy and 
diabetic donors
In our initial analysis of the proteomic dataset we noticed that neutrophils from healthy 
donors overexpressed calpastatin (an inhibitor of apoptosis in neutrophils) 25 whilst expressing 
a lower level of calpain in comparison to neutrophils from diabetic subjects (Table S1). Our 
pro-inflammatory cytokine data demonstrated that a significantly higher level of TNF, a 
cytokine with a role in induction of apoptosis, was secreted by infected diabetic cells at 
significantly higher levels a 2 hours post-infection. Previously, Chanchamroen et al. 21 
demonstrated that B. pseudomallei-infected healthy neutrophils were able to delay spontaneous 
apoptosis, whilst infected diabetic neutrophils demonstrated significantly higher levels of 
programmed cell death at 24 hours post-infection. With these data in mind, we assessed the 
induction of apoptosis in neutrophils from healthy and diabetic subjects following incubation 
with media or BTCV E555 for 2 and 24 hours (Figure 7). Cells were incubated with Annexin 
V488 and propidium iodide (PI), and assessed by flow cytometry (Figure 7C). Annexin V binds 
to apoptotic cell membranes, whereas the cell-impermeable DNA-binding PI will only enter 
cells undergoing secondary necrosis or necrosis. As previously shown by Chanchamroen et al. 
21, in our experiments neutrophils from healthy donors were significantly delayed in apoptosis 
following infection with BTCV for 2 hours (Figure 7A & 7C) and 24 hours (Figure 7B & 7C). 
Whilst uninfected neutrophils from diabetic donors displayed similar levels of spontaneous 
apoptosis over the two time points studied as the uninfected neutrophils from healthy donors, 
infection of the neutrophils from diabetics resulted in a less marked but significant delay in 
apoptosis at 2 hours post-infection (Figure 7A). This was accompanied by a small but 
significant increase in the number of cells that were both Annexin V and PI positive at 2 hours 
post-infection (labelled ‘late apoptosis’ in the figure), indicating that a proportion of cells had 
completed the apoptotic process and were in the stage of late apoptosis/ secondary necrosis, or 
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possibly undergoing cell death through necrosis or an alternative form of cell death involving 
membrane disintegration. 
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Figure 7. Assessment of apoptosis of uninfected and B. thailandensis E555-infected 
neutrophils from healthy or diabetic individuals. Neutrophils were treated with media or 
infected with B. thailandensis E555 at an MOI of 5 for 2 hours (T2, A) and 24 hours (T24, B). 
Cells were stained with annexin V488 and propidium iodine (PI) before flow cytometry analysis. 
Each bar indicates the mean ± SEM for data obtained from three independent experiments (n=3 
biological replicates). An unpaired Students t-test was used to compare the means of two 
independent sample groups, where * = p-value ≤0.05, ** = p-value ≤0.01 and *** = p-value 
≤0.001. Representative plots of data obtained from NM neutrophils before and after infection 
at 2 (T2) and 24 (T24) hours post-infection are shown in C.
One classic feature of cell death by necrosis that distinguishes this process from 
apoptosis, is a loss of plasma and nuclear membrane integrity. This can be measured by 
assessing the levels of Lactate dehydrogenase in cell supernatants, a cytoplasmic enzyme which 
is only present in the extracellular media upon disintegration of the plasma membrane. Infected 
healthy neutrophils display decreased levels of cell lysis compared to the uninfected control 
cells, at both 2 and 24 hours post-infection (Figure 8). Conversely, infection of neutrophils 
isolated from diabetic donors displayed a consistent and significant increase in cell lysis at both 
2 and 24 hours post-infection (Figure 8). This data suggests that neutrophils from diabetic 
subjects are more likely than neutrophils from healthy donors to undergo a form of lytic cell 
death, such as necrosis, upon infection with BTCV. 
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Figure 8. Assessment of cell integrity of uninfected and B. thailandensis E555-infected 
neutrophils from healthy and diabetic individuals. Neutrophils were treated with media or 
infected with B. thailandensis E555 at an MOI of 5 for 2 hours (T2) and 24 hours (T24). Cell 
supernatants were harvested and assayed for extracellular lactate dehydrogenase (LDH). Each 
bar indicates the mean ± SEM for data obtained from three independent experiments (n=3 
biological replicates). An unpaired Students t-test was used to compare the means of two 
independent sample groups, where * = p-value ≤0.05, ** = p-value ≤0.01 and *** = p-value 
≤0.001.
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CONCLUSION
Here we describe the first quantitative proteomic analysis of neutrophils from patients 
with Type 2 diabetes (Diabetes mellitus) in comparison with neutrophils from healthy 
volunteers. Furthermore, this study is the first to compare the response of these neutrophils 
upon infection with the Gram negative bacterium B. thailandensis capsule-variant strain E555, 
used here as a surrogate organism for B. pseudomallei, the causative agent of melioidosis. Our 
data provide important insights into the differential response of neutrophils from healthy and 
diabetic subjects upon infection, where neutrophils from diabetic subjects produce significantly 
more inflammatory mediators, proteins involved in oxidative stress and display an increased 
rate of cell death associated with loss of plasma membrane integrity. Overall our study presents 
novel data that will aid in a better understanding of the host: pathogen interactions involved in 
the life-threatening disease melioidosis, particularly in high risk patients.
Page 35 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
36
36
ASSOCIATED CONTENT
Data
The Mass spectrometry data have been deposited to the MassIVE archive 
(https://massive.ucsd.edu/ProteoSAFe/static/massive.jsp) with the data set identifier 
MSV000083765.
Supporting information
Table S1. List of proteins detected and their calculated abundance ratios.
Figure S1. Neutrophil isolation.
Figure S2. Diagram illustrating the proteomic workflow. 
Author contributions
Conceived and designed experiments: JMS, SK, PW, and RWT. Performed the experiments: 
PW, DK. Analyzed the data: PW, JMS, DK. Contributed reagents/materials/analysis tools: 
JMS, RWT, WT, and NP. Wrote the paper: PW, JMS, SK. 
Conflict of interests
The authors declare no competing financial interest.
Funding Sources
PW is supported by the Royal Golden Jubilee PhD programme, Thailand Research Fund (PHD 
0009/2557). JS is supported by a BBSRC Institute Strategic Programme Grant 
(BBS/E/D/20231761).
Page 36 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
37
37
ACKNOWLEDGEMENTS 
PW is supported by the Royal Golden Jubilee PhD programme, Thailand Research Fund (PHD 
0009/2557). JS is supported by a BBSRC Institute Strategic Programme Grant 
(BBS/E/D/20231761). We are especially grateful to all of our blood donors associated with 
this project. We also thank Ms. Chutima Chanprasert for her assistance in screening the diabetic 
subjects, Ms. Pucharee Songprakhon for her technical assistance with the confocal microscopy, 
and Mr. Somsak Khaimon for his technical assistance in Flow cytometry.  
ABBREVIATIONS
CFU; colony forming unit,  h; hour(s), IFN; interferon, iTRAQ; isobaric tags for relative and 
absolute quantitation, IL; interleukin, LC-MS/MS; liquid chromatography (LC) with mass 
spectrometry, PBS; phosphate-buffered saline, SDS-PAGE; sodium dodecyl sulphate 
polyacrylamide gel electrophoresis, TNF; tumour necrosis factor
Page 37 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
38
38
REFERENCES
1. Dharakul, T.; Tassaneetrithep, B.; Trakulsomboon, S.; Songsivilai, S. Phylogenetic 
analysis of Ara+ and Ara- Burkholderia pseudomallei isolates and development of a 
multiplex PCR procedure for rapid discrimination between the two biotypes. J. Clin. 
Microbiol. 1999, 37, 1906-12. 
2. Lertpatanasuwan, N.; Sermsri, K.; Petkaseam, A.; Trakulsomboon, S.; Thamlikitkul, V.; 
Suputtamongkol, Y. Arabinose-positive Burkholderia pseudomallei infection in humans: 
case report. Clin. Infect. Dis. 1999, 28, 927-8.
3. Glass, M. B.; Gee, J. E.; Steigerwalt, A. G.; Cavuoti, D.; Barton, T.; Hardy, R. D.; Godoy, 
D.; Spratt, B. G.; Clark, T. A.; Wilkins, P. P. Pneumonia and septicemia caused by 
Burkholderia thailandensis in the United States. J. Clin. Microbiol. 2006, 44, 4601-4.
4. Sim, B. M.; Chantratita, N.; Ooi, W. F.; Nandi, T.; Tewhey, R.; Wuthiekanun, V.; 
Thaipadungpanit, J.; Tumapa, S.; Ariyaratne, P.; Sung, W. K.; Sem, X. H.; Chua, H. H.; 
Ramnarayanan, K.; Lin, C. H.; Liu, Y.; Feil, E. J.; Glass, M. B.; Tan, G.; Peacock, S. J.; 
Tan, P. Genomic acquisition of a capsular polysaccharide virulence cluster by non-
pathogenic Burkholderia isolates. Gen. Biol. 2010, 11, R89.
5. Scott, A. E.; Laws, T. R.; D'Elia, R. V.; Stokes, M. G.; Nandi, T.; Williamson, E. D.; Tan, 
P.; Prior, J. L.; Atkins, T. P. Protection against experimental melioidosis following 
immunization with live Burkholderia thailandensis expressing a manno-heptose capsule. 
Clin. Vaccine Immunol. 2013, 20, 1041-7. 
6. Ulett, G. C.; Ketheesan, N.; Hirst, R. G. Cytokine gene expression in innately susceptible 
BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent 
Burkholderia pseudomallei. Infect. Immun. 2000, 68, 2034-42.
Page 38 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
39
39
7. Barnes, J. L.; Ulett, G. C.; Ketheesan, N.; Clair, T.; Summers, P. M.; Hirst, R. G. Induction 
of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia 
pseudomallei infection. Immunol. Cell Biol. 2001, 79, 490-501.
8. Easton, A.; Haque, A.; Chu, K.; Lukaszewski, R.; Bancroft, G. J. A critical role for 
neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. 
Infect. Dis. 2007, 195, 99-107.
9. Wiersinga, W. J.; Dessing, M. C.; Kager, P. A.; Cheng, A. C.; Limmathurotsakul, D.; Day, 
N. P.; Dondorp, A. M.; van der Poll, T.; Peacock, S. J. High-throughput mRNA profiling 
characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia 
pseudomallei. Infect. Immun. 2007, 75, 3074-9.
10. Laws, T. R.; Smither, S. J.; Lukaszewski, R. A.; Atkins, H. S. Neutrophils are the 
predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse 
model of respiratory melioidosis. Microb. Pathog. 2011, 51, 471-5.
11. Jones, A. L.; Beveridge, T. J.; Woods, D. E. Intracellular survival of Burkholderia 
pseudomallei. Infect. Immun. 1996, 64, 782-90.
12. Santanirand, P.; Harley, V. S.; Dance, D. A.; Drasar, B. S.; Bancroft, G. J. Obligatory role 
of gamma interferon for host survival in a murine model of infection with Burkholderia 
pseudomallei. Infect. Immun. 1999, 67, 3593-600.
13. Haque, A.; Easton, A.; Smith, D.; O'Garra, A.; Van Rooijen, N.; Lertmemongkolchai, G.; 
Titball, R. W.; Bancroft, G. J. Role of T cells in innate and adaptive immunity against 
murine Burkholderia pseudomallei infection. J. Infect. Dis. 2006, 193, 370-9.
14. Ulett, G. C.; Ketheesan, N.; Hirst, R. G. Proinflammatory cytokine mRNA responses in 
experimental Burkholderia pseudomallei infection in mice. Acta Trop. 2000, 74, 229-34.
15. Riyapa, D.; Buddhisa, S.; Korbsrisate, S.; Cuccui, J.; Wren, B. W.; Stevens, M. P.; Ato, 
M.; Lertmemongkolchai, G. Neutrophil extracellular traps exhibit antibacterial activity 
Page 39 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
40
40
against Burkholderia pseudomallei and are influenced by bacterial and host factors. 
Infect. Immun. 2012, 80, 3921-9.
16. Rinchai, D.; Riyapa, D.; Buddhisa, S.; Utispan, K.; Titball, R. W.; Stevens, M. P.; 
Stevens, J. M.; Ogawa, M.; Tanida, I.; Koike, M.; Uchiyama, Y.; Ato, M.; 
Lertmemongkolchai, G. Macroautophagy is essential for killing of intracellular 
Burkholderia pseudomallei in human neutrophils. Autophagy 2015, 11, 748-55.
17. Simpson, A. J.; Newton, P. N.; Chierakul, W.; Chaowagul, W.; White, N. J. Diabetes 
mellitus, insulin, and melioidosis in Thailand. Clin. Infect. Dis. 2003, 36, e71-2.
18. Alba-Loureiro, T. C.; Hirabara, S. M.; Mendonca, J. R.; Curi, R.; Pithon-Curi, T. C. 
Diabetes causes marked changes in function and metabolism of rat neutrophils. J. 
Endocrinol. 2006, 188, 295-303.
19. Schuetz, P.; Castro, P.; Shapiro, N. I. Diabetes and Sepsis: Preclinical Findings and 
Clinical Relevance. 2011 Diabetes Care 34, 771-8.
20. Koh, G. C. K. W.; Peacock, S. J.; van der Poll, T.; Wiersinga, W. J. The Impact of 
diabetes on the pathogenesis of sepsis. 2012 Eur. J. Clin. Microbiol. Infect. Dis. 31, 379-
88.
21. Chanchamroen, S.; Kewcharoenwong, C.; Susaengrat, W.; Ato, M.; Lertmemongkolchai, 
G. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in 
healthy and diabetic subjects. Infect. Immun. 2009, 77, 456-63.
22. Rappsilber, J.; Mann, M.; Ishihama, Y. Protocol for micro-purification, enrichment, pre-
fractionation and storage of peptides for proteomics using StageTips. Nat. protoc. 2007, 
2, 1896-906.
23. Kewcharoenwong, C.; Rinchai, D.; Utispan, K.; Suwannasaen, D.; Bancroft, G. J.; Ato, 
M.; Lertmemongkolchai, G. Glibenclamide reduces pro-inflammatory cytokine 
Page 40 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
41
41
production by neutrophils of diabetes patients in response to bacterial infection. Sci. Rep. 
2013, 3, 3363.
24. Vanaporn, M.; Wand, M.; Michell, S. L.; Sarkar-Tyson, M.; Ireland, P.; Goldman, S.; 
Kewcharoenwong, C.; Rinchai, D.; Lertmemongkolchai, G.; Titball, R. W. Superoxide 
dismutase C is required for intracellular survival and virulence of Burkholderia 
pseudomallei. Microbiol. 2011, 157, 2392-400.
25. Squier, M. K.; Sehnert, A. J.; Sellins, K. S.; Malkinson, A. M.; Takano, E.; Cohen, J. J. 
Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 1999, 178, 311-9.
26. Urban, C. F.; Ermert, D.; Schmid, M.; Abu-Abed, U.; Goosmann, C.; Nacken, W.; 
Brinkmann, V.; Jungblut, P. R.; Zychlinsky, A. Neutrophil extracellular traps contain 
calprotectin, a cytosolic protein complex involved in host defense against Candida 
albicans. PLoS pathog. 2009, 5, e1000639.
27. O'Donoghue, A. J.; Jin, Y.; Knudsen, G. M.; Perera, N. C.; Jenne, D. E.; Murphy, J. E.; 
Craik, C. S.; Hermiston, T. W. Global substrate profiling of proteases in human 
neutrophil extracellular traps reveals consensus motif predominantly contributed by 
elastase. PloS one 2013, 8, e75141.
28. Lim, C. H.; Adav, S. S.; Sze, S. K.; Choong, Y. K.; Saravanan, R.; Schmidtchen, A. 
Thrombin and Plasmin Alter the Proteome of Neutrophil Extracellular Traps. Front. 
Immunol. 2018, 9, 1554.
29. Kusminski, C. M.; McTernan, P. G.; Kumar, S. Role of resistin in obesity, insulin 
resistance and Type II diabetes. Clin. Sci. 2005, 109, 243-56.
30. Jiang, S.; Park, D. W.; Tadie, J. M.; Gregoire, M.; Deshane, J.; Pittet, J. F.; Abraham, E.; 
Zmijewski, J. W. Human resistin promotes neutrophil proinflammatory activation and 
neutrophil extracellular trap formation and increases severity of acute lung injury. J. 
Immunol. 2014, 192, 4795-803.
Page 41 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
42
42
31. Lacy, P., Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immun 2006, 
2, 98-108.
32. Morris, J.; Williams, N.; Rush, C.; Govan, B.; Sangla, K.; Norton, R.; Ketheesan, N. 
Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood 
model of type 2 diabetes-melioidosis comorbidity. Infect. Immun. 2012, 80, 2089-99.
33. de Jong, H. K.; Koh, G. C.; Achouti, A.; van der Meer, A. J.; Builder, I.; Stephan, F.; 
Roeloffs, J. J.; Day N. P.; Peacock, S. J.; Zeerleder, S.; Wiersinga, W. J. Neutrophil 
extracellular traps in the host defense against sepsis induced by Burkholderia 
pseudomallei (melioidosis) 2014 Intensive Care Med. Exp. 2, 21.
34. Aratani, Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil 
function. Arch. Biochem. Biophys. 2018, 640, 47-52.
35. Ferretti, S.; Bonneau, O.; Dubois, G. R.; Jones, C. E.; Trifilieff, A. IL-17, produced by 
lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway 
neutrophilia: IL-15 as a possible trigger. J. Immunol. 2003, 170, 2106-12.
36. Fatima, N.; Faisal, S. M.; Zubair, S.; Siddiqui, S. S.; Moin, S.; Owais, M. Emerging role 
of Interleukins IL-23/IL-17 axis and biochemical markers in the pathogenesis of Type 2 
Diabetes: Association with age and gender in human subjects. Int. J. Biol. Macromol. 
2017, 105, 1279-1288.
Page 42 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
43
43
For TOC Only
Page 43 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 1 
190x275mm (96 x 96 DPI) 
Page 44 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 2 
190x275mm (96 x 96 DPI) 
Page 45 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 3 
190x275mm (96 x 96 DPI) 
Page 46 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 4 
190x275mm (96 x 96 DPI) 
Page 47 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 5 
190x275mm (96 x 96 DPI) 
Page 48 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 6 
190x275mm (96 x 96 DPI) 
Page 49 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 7 
190x275mm (96 x 96 DPI) 
Page 50 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Figure 8 
190x275mm (96 x 96 DPI) 
Page 51 of 51
ACS Paragon Plus Environment
Journal of Proteome Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
